|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Articles |
The use of theophylline for the treatment of asthma for 45 of the past 50 years has been for its ability to dilate bronchi. The problem has been that at the most effective bronchodilating dose, toxicity was too close for comfort. In the past 5 years, there has been resurgence in theophylline use at lower doses because of some well-documented anti-inflammatory and steroid sparing effects.
This article has been cited by other articles:
![]() |
E. Bancalari Caffeine for Apnea of Prematurity N. Engl. J. Med., May 18, 2006; 354(20): 2179 - 2181. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |